Pharmaprojects: track pharma R&D

Pharmaprojects, Citeline

Pharma R&D Annual Review & NAS Supplement 2021

Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible? 

Topic Clinical Trials Diseases Drug Review

Topic Clinical Trial Optimization Clinical Trials

Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet...

COVID-19 Infographic

Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.

Topic Coronavirus

Pharmaprojects

Pharma RD Annual Review 2020 Whitepaper

Using the new, granular datapoints in Pharmaprojects, Senior Director Ian Lloyd presents his expert insights into pharma’s R&D activities over the past year and what they may mean for the pipeline during the year to come. The 27th instalment of the Annual Review, this version takes advantage of improvements to Pharmaprojects’ data granularity to bring you details on pharma R&D trends

Topic Drug Development Landscape Drug Review Research & Development

Pharmaprojects

New Active Substances (NAS) Launched During 2019 Infographic

Don’t miss your view into the NAS that made an impact last year, your follow-up to the Pharma R&D Annual Review 2020 webinar.

Topic Clinical Trials Research & Development

Pharmaprojects

Pharma R&D Annual Review 2020 Whitepaper - NAS Supplement

Recently, Pharma Intelligence brought you the Pharma R&D Annual Review 2020 Webinar, followed up with the NAS (New Active Substances) Infographic. We now invite you to go even deeper into pharma R&D successes for 2019 with your free copy of the NAS Supplement. 

Topic Clinical Trials Research & Development

Pharmaprojects

Pharma R&D Review 2020 Webinar

The pharma industry is moving into a new decade, and Pharmaprojects is here with insights into what we can expect in the year ahead. Join us to examine the trends and pipelines in a new level of granular detail. Get a taste of the direction R&D is heading in the Pharma R&D Annual Review Webinar.

Topic Clinical Trials Drug Development Landscape

Pharmaprojects

Pharma RD Annual Review 2020 Infographic

Using new, granular data from Pharmaprojects, part of the Citeline suite of tools, this infographic will explore: The 2020 Pipeline by Phase Top Companies Mechanisms and Targets Types of Pipeline Drugs

Topic Research & Development Drug Development Landscape Drug Review

Pharmaprojects, Biomedtracker

The Race to Find a COVID-19 Treatment - Infographic

Access this infographic which focuses on Gilead’s drug Remdesivir which currently shows the greatest promise for the likelihood of approval as a possible treatment to effectively treat the virus. The infographic highlights the drug summary and profile, the number of patients in each trial phase, and the history of events that have moved this product through the development process.

Topic Coronavirus FDA Drug Review

Citeline, Pharmaprojects

New Active Substances (NAS) LAUNCHED DURING 2018

For a snapshot of the new active substances (NAS) successfully launched last year, download the data-packed New Active Substances (NAS) Launched During 2018 infographic from Citeline.

Topic Drug approval Drug development landscape Drug review

Citeline, Sitetrove, Trialtrove, Pharmaprojects

Citeline: Global Clinical Trial Intelligence Solutions

Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

Topic Clinical trials Clinical trial optimization

Citeline, Pharmaprojects

Pharma RD Annual Review 2019 Supplement New Active Substances Launched During 2018

Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successfully launched to market last year.

Topic Drug approval Drug development landscape Drug review

Pharmaprojects

Pharmaprojects 2018 Pharma R&D Infographic

Will the Pharma R&D Annual Review 2018 from Citeline’s Pharmaprojects be music to your ears, or will it sound a sour note? Find out with the Pharma R&D Annual Review 2018 infographic, now available to you as a free download.

Topic Drug development landscape